Biogen

Biogen is a leading global biotechnology company specializing in the discovery, development, and delivery of innovative therapies for neurological and neurodegenerative diseases. With a strong focus on research and development, Biogen is recognized for its advancements in treatments for conditions such as multiple sclerosis and spinal muscular atrophy. The company operates a significant production facility in Luterbach, Switzerland, which plays a crucial role in meeting the demands of the American market.